Proud to announce our $45M Series B to expand our platform into therapeutics & broaden access to our #CRISPR IP to develop clinical applications w/ unprecedented speed/accuracy. Thanks to @MayfieldFund @NFX & all our investors. Read more via @SynBioBeta:http://bit.ly/319NjYs
-
Prikaži ovu nit
One of the many things we're doing with this funding - hiring! Check out openings ranging from Research Associates & Scientists to Project Manager & Director of #GenomeEditing here: https://mammoth.bio/careers/ #ScienceCareers #StemCareers #Biotech
0 replies
1 proslijeđeni tweet
5 korisnika označava da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.